Your browser doesn't support javascript.
loading
Targeting 3D chromosomal architecture at the RANK loci to suppress myeloma-driven osteoclastogenesis.
Thümmler, Katja; Williams, Mark Ts; Kitson, Susan; Sood, Shatakshi; Akbar, Moeed; Cole, John J; Hunter, Ewan; Soutar, Richard; Goodyear, Carl S.
Afiliação
  • Thümmler K; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Williams MT; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Kitson S; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Sood S; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Akbar M; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Cole JJ; GLAZgo Discovery Centre, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Hunter E; Oxford BioDynamics, Oxford, UK.
  • Soutar R; Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Glasgow, UK.
  • Goodyear CS; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Oncoimmunology ; 11(1): 2104070, 2022.
Article em En | MEDLINE | ID: mdl-35936985
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteogênese / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteogênese / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido